Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fampridine in Spinocerebellar Ataxia SCA27B
NCT07185347Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dalfampridine in spinocerebellar ataxia type 27b (SCA27B), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2025; status: recruiting.
02
Drugs
dalfampridine
03
Conditions
spinocerebellar ataxia type 27b (SCA27B)
Beyond the preview
Go deeper on NCT07185347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07185347.